Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Comprehensive Interrogation of Synthetic Lethality in the DNA Damage Response

PROVIDER: PRJNA988447 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25050632_1.fastq.gz	Fastqsanger.gz
	SRR25050632_2.fastq.gz	Fastqsanger.gz
	SRR25050633_1.fastq.gz	Fastqsanger.gz
	SRR25050633_2.fastq.gz	Fastqsanger.gz
	SRR25050634_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Comprehensive Interrogation of Synthetic Lethality in the DNA Damage Response

Project description:Comprehensive Interrogation of Synthetic Lethality in the DNA Damage Response

| PRJNA988524 | ENA

DNA damage induced by G-quadruplex ligand PyBI and its synthetic lethality with DNA repair inhibitors in cancer cells

Project description:The existence of G-quadruplexes (G4s) in vivo verified by diverse techniques, accompanied with their regulatory roles in cellular processes, highlight G4s as a target for various disease treatment. Targeting G-quadruplex DNAs to cause DNA damage has a good prospect for cancer therapy. However, previous studies on DNA damage induced by G4 ligands and its repair response thereof mainly focused on limited scaffolds such as CX series drugs, PDS families, etc. Here, we systematically investigated the DNA damage and repair mechanism induced by a good G4 stabilizer with bis(benzimidazole)pyridine as its key scaffold, which we termed as PyBI. PyBI can stabilize G4s both in vitro and in vivo, and cause DNA double strand breaks (DSB) and genome instability during DNA replication, resulting in cell cycle stagnation in G2/M phase and the increase of RAD51 and 53BP1 foci. Significantly, we applied Cleavage Under Targets and Tagmentation (CUT&Tag) for genome-wide mapping DNA damage sites induced by PyBI in cancer cells. Together with its G4 mapping result by CUT&Tag, we revealed that DNA damage caused by PyBI might be mediated by G4 stabilization. Moreover, we thoroughly investigated the synthetic lethality of PyBI with a small library of DNA repair inhibitors. PyBI exhibited good synthetic lethality effects with RAD51 and DNA-PK inhibitor, providing a new prospect for the treatment of genetically defective cancers.

2025-05-29 | GSE270287 | GEO

EDU-IP-MS of ecDNA positive and negative human COLO320, HEK293T and U251 cell lines

Project description:In this study, we established ecDNA-containing cell models by either transfecting synthetic circular DNA or excising endogenous chromosomal DNA. We found that ecDNA can be stable maintained in these cell models. By identifying proteins on nascent DNA, we found DNA damage repair pathway was significantly enriched in ecDNA-containing cells. ecDNA can activate DNA damage response. Further evidence show that TOP2B and LIG3. The association of ecDNA replication with cell proliferation and DNA damage response was explored by comprehensive profiling and analysis. Utilizing EdU (5-ethynyl-2’-deoxyuridine)-immunoprecipitation-mass spectrometry (EdU-IP-MS), we identified critical regulators involved in ecDNA replication and examined their functional roles in cancer cell DNA damage response and proliferation.

2025-04-18 | PXD060725 | Pride

Project description:Functional interrogation of DNA damage response variants with base editing screens

| PRJNA689217 | ENA

Activation of the ATR kinase by the RPA-binding protein ETAA1

Project description:The ATR kinase is a master regulator of cellular responses to DNA damage and replication stress that is activated by a complex mechanism involving its binding partner ATRIP, RPA-coated ssDNA, the 9-1-1 complex and TopBP1. Here, we discovered a new ATR activation mechanism in human cells, mediated by the uncharacterized protein ETAA1 (Ewing’s tumor-associated antigen 1). From a comprehensive proteomic survey of protein recruitment to DNA double-strand break-modified chromatin, we identified ETAA1 as a factor that accumulates at DNA damage sites via an RPA-binding motif, and which has an important role in promoting cell survival and preventing replication fork breakage after genotoxic insults. Mechanistically, we show that ETAA1 harbors a conserved domain that potently and directly stimulates ATR kinase activity independent of TopBP1 and 9-1-1, and which is essential for the function of ETAA1 in the DNA damage response. Consistently, ablation of ETAA1 shows profound synthetic lethality with TopBP1 knockdown, resulting from massive replication fork collapse and abrogation of ATR-dependent signaling. Finally, we show that ETAA1 levels in cancer cell lines inversely correlate with their dependency on TopBP1 for ATR activation, and that overexpression of ETAA1 partially restores ATR-dependent signaling after loss of TopBP1. Together, these findings establish a new mechanism of ATR activation in human cells that operates in parallel with, but independent of, the canonical TopBP1-mediated pathway.

2016-09-30 | PXD003529 | Pride

Saccharomyces cerevisiae

Project description:SML1 synthetic lethality

| PRJNA90309 | ENA

Saccharomyces cerevisiae

Project description:BIM1 synthetic lethality

| PRJNA90507 | ENA

Saccharomyces cerevisiae

Project description:CDC102 synthetic lethality

| PRJNA90513 | ENA

Saccharomyces cerevisiae

Project description:SGS1 synthetic lethality